ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.695
      -0.25%
      Bitcoin
      58,842.42
      -2.19%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Hikma Pharmaceuticals Plc (HIK)

      7. Hikma Pharmaceuticals Plc (HIK) News

      HIK

      Hikma Pharmaceuticals (HIK)

      Hikma Pharmaceuticals Plc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:HIK
      DateTimeSourceHeadlineSymbolCompany
      1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
      05/06/202212:54PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      05/05/202212:47PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      05/05/20224:24AMAlliance NewsAlliance NewsTOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drugLSE:HIKHikma Pharmaceuticals Plc
      05/05/20224:24AMAlliance NewsAlliance NewsTOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drugLSE:HIKHikma Pharmaceuticals Plc
      05/05/20222:01AMUK RegulatoryHikma Pharmaceuticals Plc Hikma updates Generics guidance for 2022LSE:HIKHikma Pharmaceuticals Plc
      05/04/202212:58PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      05/03/20221:08PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/29/20221:42PMPR Newswire (US)Hikma confirms that it has not signed a licensing agreement with Opiant PharmaceuticalsLSE:HIKHikma Pharmaceuticals Plc
      04/29/20221:33PMPR Newswire (US)Hikma confirms that it has not signed a licensing agreement with Opiant PharmaceuticalsLSE:HIKHikma Pharmaceuticals Plc
      04/29/202212:44PMAlliance NewsAlliance NewsIN BRIEF: Hikma says has not entered license agreement with OpiantLSE:HIKHikma Pharmaceuticals Plc
      04/29/202212:44PMAlliance NewsAlliance NewsIN BRIEF: Hikma says has not entered license agreement with OpiantLSE:HIKHikma Pharmaceuticals Plc
      04/29/202212:29PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/29/202212:05PMUK RegulatoryHikma Pharmaceuticals Plc Correction statement re OpiantLSE:HIKHikma Pharmaceuticals Plc
      04/29/20224:09AMAlliance NewsAlliance NewsHikma Pharmaceuticals notes "slow" start for Generics business in 2022LSE:HIKHikma Pharmaceuticals Plc
      04/29/20224:09AMAlliance NewsAlliance NewsHikma Pharmaceuticals notes "slow" start for Generics business in 2022LSE:HIKHikma Pharmaceuticals Plc
      04/29/20222:15AMUK RegulatoryHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
      04/28/20221:05PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/27/20221:17PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/27/20222:01AMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/25/20221:05PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/25/202210:42AMUK RegulatoryHikma Pharmaceuticals Plc Result of AGMLSE:HIKHikma Pharmaceuticals Plc
      04/25/20222:01AMUK RegulatoryHikma Pharmaceuticals Plc Notice of GMLSE:HIKHikma Pharmaceuticals Plc
      04/22/20221:16PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/21/20221:06PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
      04/21/20229:37AMAlliance NewsAlliance NewsIN BRIEF: Hikma Pharmaceuticals completes Custopharm dealLSE:HIKHikma Pharmaceuticals Plc
      04/21/20229:37AMAlliance NewsAlliance NewsIN BRIEF: Hikma Pharmaceuticals completes Custopharm dealLSE:HIKHikma Pharmaceuticals Plc
      04/21/20229:28AMPR Newswire (US)Hikma completes acquisition of CustopharmLSE:HIKHikma Pharmaceuticals Plc
      04/21/20229:15AMUK RegulatoryHikma Pharmaceuticals Plc AcquisitionLSE:HIKHikma Pharmaceuticals Plc
      04/20/202212:59PMUK RegulatoryHikma Pharmaceuticals Plc Transaction in Own SharesLSE:HIKHikma Pharmaceuticals Plc
       Showing the most relevant articles for your search:LSE:HIK

      Your Recent History

      USOTC
      ZHYBF
      Zhong Yuan BioTechnology (QB)
      Delayed Upgrade Clock